These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 3335409)

  • 21. Conservation of an Actinomyces viscosus T14V type 1 fimbrial subunit homolog among divergent groups of Actinomyces spp.
    Yeung MK
    Infect Immun; 1992 Mar; 60(3):1047-54. PubMed ID: 1347285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fimbriae of Actinomyces viscosus t14v: their relationship to the virulence-associated antigen and to coaggregation with Streptococcus sanguis 34.
    Cisar JO; McIntire FC; Vatter AE
    Adv Exp Med Biol; 1978; 107():695-701. PubMed ID: 84522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adherence of Actinomyces viscosus T14V and T14AV to hydroxyapatite surfaces in vitro and human teeth in vivo.
    Wheeler TT; Clark WB; Birdsell DC
    Infect Immun; 1979 Sep; 25(3):1066-74. PubMed ID: 500185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coaggregation properties of human oral Veillonella spp.: relationship to colonization site and oral ecology.
    Hughes CV; Kolenbrander PE; Andersen RN; Moore LV
    Appl Environ Microbiol; 1988 Aug; 54(8):1957-63. PubMed ID: 3178207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies against the Ag2 fimbriae of Actinomyces viscosus T14V inhibit lactose-sensitive bacterial adherence.
    Revis GJ; Vatter AE; Crowle AJ; Cisar JO
    Infect Immun; 1982 Jun; 36(3):1217-22. PubMed ID: 6124506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutants of Actinomyces viscosus T14V lacking type 1, type 2, or both types of fimbriae.
    Cisar JO; Vatter AE; Clark WB; Curl SH; Hurst-Calderone S; Sandberg AL
    Infect Immun; 1988 Nov; 56(11):2984-9. PubMed ID: 2902012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A study of in vitro attachment of Streptococcus sanguis and Actinomyces viscosus to saliva-treated titanium.
    Wolinsky LE; de Camargo PM; Erard JC; Newman MG
    Int J Oral Maxillofac Implants; 1989; 4(1):27-31. PubMed ID: 2599579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of saliva on coaggregation of oral Actinomyces and Streptococcus species.
    Kolenbrander PE; Phucas CS
    Infect Immun; 1984 May; 44(2):228-33. PubMed ID: 6370861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coaggregation of oral Bacteroides species with other bacteria: central role in coaggregation bridges and competitions.
    Kolenbrander PE; Andersen RN; Holdeman LV
    Infect Immun; 1985 Jun; 48(3):741-6. PubMed ID: 3888842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of surface fimbriae (fibrils) in the adsorption of Actinomyces species to saliva-treated hydroxyapatite surfaces.
    Clark WB; Webb EL; Wheeler TT; Fischlschweiger W; Birdsell DC; Mansheim BJ
    Infect Immun; 1981 Sep; 33(3):908-17. PubMed ID: 6169645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modification of surface composition of Actinomyces viscosus T14V and T14AV.
    Powell JT; Fischlschweiger W; Birdsell DC
    Infect Immun; 1978 Dec; 22(3):934-44. PubMed ID: 730385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Model studies on dental plaque formation: deoxyhexoses in Actinomyces viscosus.
    Tylenda CA; Charon D; Lombardi FP; Gabriel O
    Infect Immun; 1979 Feb; 23(2):312-9. PubMed ID: 570555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kinetics of lactose-reversible coadhesion of Actinomyces naeslundii WVU 398A and Streptococcus oralis 34 on the surface of hexadecane droplets.
    Ellen RP; Veisman H; Buivids IA; Rosenberg M
    Oral Microbiol Immunol; 1994 Dec; 9(6):364-71. PubMed ID: 7870472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Construction and use of integration plasmids to generate site-specific mutations in the Actinomyces viscosus T14V chromosome.
    Yeung MK
    Infect Immun; 1995 Aug; 63(8):2924-30. PubMed ID: 7622214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural preferences of beta-galactoside-reactive lectins on Actinomyces viscosus T14V and Actinomyces naeslundii WVU45.
    McIntire FC; Crosby LK; Barlow JJ; Matta KL
    Infect Immun; 1983 Aug; 41(2):848-50. PubMed ID: 6874075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular basis of bacterial adhesion in the oral cavity.
    Mergenhagen SE; Sandberg AL; Chassy BM; Brennan MJ; Yeung MK; Donkersloot JA; Cisar JO
    Rev Infect Dis; 1987; 9 Suppl 5():S467-74. PubMed ID: 2891180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novobiocin-resistant mutants of Streptococcus sanguis with reduced cell hydrophobicity and defective in coaggregation.
    Jenkinson HF
    J Gen Microbiol; 1987 Jul; 133(7):1909-18. PubMed ID: 3312487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigenic relationships among oral Actinomyces isolates, Actinomyces naeslundii genospecies 1 and 2, Actinomyces howellii, Actinomyces denticolens, and Actinomyces slackii.
    Putnins EE; Bowden GH
    J Dent Res; 1993 Oct; 72(10):1374-85. PubMed ID: 8408879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specific coaggregation and the cell wall of Streptococcus sanguis.
    Reusch VM; Foster JL; Haberkorn DS
    J Bacteriol; 1983 Aug; 155(2):896-9. PubMed ID: 6874647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a 95 kDa putative adhesin from Actinomyces serovar WVA963 strain PK1259 that is distinct from type 2 fimbrial subunits.
    Klier CM; Kolenbrander PE; Roble AG; Marco ML; Cross S; Handley PS
    Microbiology (Reading); 1997 Mar; 143 ( Pt 3)():835-846. PubMed ID: 9084167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.